These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32916153)

  • 1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice.
    Merino B; Fernández-Díaz CM; Parrado-Fernández C; González-Casimiro CM; Postigo-Casado T; Lobatón CD; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2020 Dec; 113():154352. PubMed ID: 32916153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits.
    Borges DO; Patarrão RS; Ribeiro RT; de Oliveira RM; Duarte N; Belew GD; Martins M; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Raposo JF; Jones JG; Penha-Gonçalves C; Macedo MP
    Metabolism; 2021 May; 118():154735. PubMed ID: 33631143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.
    González-Casimiro CM; Cámara-Torres P; Merino B; Diez-Hermano S; Postigo-Casado T; Leissring MA; Cózar-Castellano I; Perdomo G
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.
    Villa-Pérez P; Merino B; Fernández-Díaz CM; Cidad P; Lobatón CD; Moreno A; Muturi HT; Ghadieh HE; Najjar SM; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2018 Nov; 88():1-11. PubMed ID: 30098324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exercise restores insulin clearance in diet-induced obese mice.
    Kurauti MA; Costa-Júnior JM; Ferreira SM; Dos Santos GJ; Protzek AO; Nardelli TR; de Rezende LF; Boschero AC
    J Endocrinol; 2016 Jun; 229(3):221-32. PubMed ID: 27000684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme.
    Protzek AO; Rezende LF; Costa-Júnior JM; Ferreira SM; Cappelli AP; de Paula FM; de Souza JC; Kurauti MA; Carneiro EM; Rafacho A; Boschero AC
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):1-8. PubMed ID: 26386462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing.
    Brandimarti P; Costa-Júnior JM; Ferreira SM; Protzek AO; Santos GJ; Carneiro EM; Boschero AC; Rezende LF
    J Endocrinol; 2013 Nov; 219(2):173-82. PubMed ID: 23959080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and Function by Inhibiting the PPARγ Pathway.
    Su Q; Huang J; Chen X; Wang Y; Shao M; Yan H; Chen C; Ren H; Zhang F; Ni Y; Jose PA; Zhong J; Yang J
    Mol Nutr Food Res; 2023 Apr; 67(7):e2200589. PubMed ID: 36726048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice.
    Vettorazzi JF; Kurauti MA; Soares GM; Borck PC; Ferreira SM; Branco RCS; Michelone LSL; Boschero AC; Junior JMC; Carneiro EM
    Sci Rep; 2017 Nov; 7(1):14876. PubMed ID: 29093479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.
    Fernández-Díaz CM; Merino B; López-Acosta JF; Cidad P; de la Fuente MA; Lobatón CD; Moreno A; Leissring MA; Perdomo G; Cózar-Castellano I
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E805-E819. PubMed ID: 31479304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.
    Wei X; Ke B; Zhao Z; Ye X; Gao Z; Ye J
    PLoS One; 2014; 9(4):e95399. PubMed ID: 24740421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice.
    Soares GM; Lopes LES; Balbo SL; Marmentini C; Bronczek GA; Kurauti MA; Bonfleur ML; Velloso LA; Carneiro EM; Boschero AC; Costa-Júnior JM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats.
    Taschetto APD; Zimath PL; Silvério R; Dos Santos C; Boschero AC; Dos Santos GJ; Rafacho A
    Life Sci; 2021 Jul; 277():119509. PubMed ID: 33865877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.
    Kulas JA; Franklin WF; Smith NA; Manocha GD; Puig KL; Nagamoto-Combs K; Hendrix RD; Taglialatela G; Barger SW; Combs CK
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E106-E120. PubMed ID: 30422705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagotomy Reduces Insulin Clearance in Obese Mice Programmed by Low-Protein Diet in the Adolescence.
    Lubaczeuski C; Gonçalves LM; Vettorazzi JF; Kurauti MA; Santos-Silva JC; Bonfleur ML; Boschero AC; Costa-Júnior JM; Carneiro EM
    Neural Plast; 2017; 2017():9652978. PubMed ID: 28951790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors.
    Kabir M; Iyer MS; Richey JM; Woolcott OO; Asare Bediako I; Wu Q; Kim SP; Stefanovski D; Kolka CM; Hsu IR; Catalano KJ; Chiu JD; Ionut V; Bergman RN
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E747-58. PubMed ID: 26306598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice.
    Rezende LF; Camargo RL; Branco RC; Cappelli AP; Boschero AC; Carneiro EM
    Br J Nutr; 2014 Sep; 112(6):900-7. PubMed ID: 25036874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota impairs insulin clearance in obese mice.
    Foley KP; Zlitni S; Duggan BM; Barra NG; Anhê FF; Cavallari JF; Henriksbo BD; Chen CY; Huang M; Lau TC; Plante R; Schwab M; Marette A; Schertzer JD
    Mol Metab; 2020 Dec; 42():101067. PubMed ID: 32860984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
    Abdul-Hay SO; Kang D; McBride M; Li L; Zhao J; Leissring MA
    PLoS One; 2011; 6(6):e20818. PubMed ID: 21695259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.